Clinical Trial Update: 18F-DCFPyL Positron Emission Tomography (PET) in Intermediate or High Risk Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating 18F-DCFPyL PET imaging in intermediate/high risk prostate cancer; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• 18F-DCFPyL (DCFPyL radiotracer for PSMA imaging)

Snippet

Sponsor: Ashok Muthukrishnan | Conditions: Prostate Cancer | Phase 2 | Status: TERMINATED | Results posted: 2024-02-15